Poly-Med
Private Company
Total funding raised: $4.3M
Overview
Poly-Med is a private, established player in the medical device and drug delivery sectors, operating as a full-service contract development and manufacturing organization (CDMO) focused exclusively on absorbable polymers and implants. Founded in 1993, the company leverages deep expertise in polymer science and vertically integrated manufacturing to partner with medical device and pharmaceutical companies, transforming their concepts into commercial products. Its core value proposition is providing end-to-end services—from polymer synthesis and material development to extrusion, textile formation, electrospinning, 3D printing, and finished device assembly—all under an ISO 13485 certified quality system. Poly-Med's technology enables next-generation implants that improve healing compliance and reduce long-term complications.
Technology Platform
Vertically integrated platform for designing, synthesizing, and processing custom absorbable polymers into medical devices via extrusion, textile manufacturing, electrospinning, 3D printing, and combination drug-device formulation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Poly-Med competes with large, diversified polymer suppliers (e.g., Corbion, Evonik) that sell absorbable resins, and with broad-scale medical device contract manufacturers. Its differentiation lies in its deep, exclusive focus on absorbables, vertical integration from polymer synthesis to finished device, and its suite of specialized fabrication technologies like electrospinning and absorbable 3D printing.